Ad5E2F-delivered E2F-1 (MD Anderson Cancer Center)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAd5E2F-delivered E2F-1 (MD Anderson Cancer Center)
Drug Alias Nameoncolytic adenovirus expressing E2F-1 transcription factor (MD Anderson Cancer Center)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionTranscription factors modulators
TargetsTranscription factors
Therapy Area/IndicationsSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsSarcoma

Other Information

ATC CodeN/A
Related LinksN/A